Basic Sciences of Oncology

Basic Sciences of Oncology Program

In 2009, MOGA launched a new educational program for medical oncology advanced trainees to be run on annual or biennial basis: the MOGA Basic Sciences of Oncology Weekend. This professional training opportunity aims to provide a scientific basis of cellular mechanisms and treatments used in oncology to form a solid knowledge basis for understanding treatments and clinical trials.
 
Basic Sciences of Oncology is open to Australian trainees in medical oncology at no cost to participants. Supervisors are requested to release medical oncology trainees from their normal duties so that they can participate.
 
Basic Sciences of Oncology reviews the following topics with expert speakers:

• Cell cycle and chemotherapy
• Targeted therapies
• Vaccines and cancer
• Molecular pathology testing
• Familial cancer and genetics

Basic Sciences of Oncology 2009

The 2009 Basic Sciences of Oncology Weekend was supported by an unrestricted educational grant from GlaxoSmithKline. The 2009 speakers were:

• A/Prof Grant McArthur
• Dr Ben Solomon
• Dr David Thomas
• A/Prof Adrienne Morey
• A/Prof Judy Kirk
• Convenor Prof Michael Brown 

Click here to view presentations (for Trainees and Members only).
 

Basic Sciences of Oncology Program 2010

The MOGA Basic Sciences of Oncology Program was a one and a half day professional training opportunity for advanced trainees in medical oncology in Australia and New Zealand held on March 27-28, supported by an unrestricted educational grant from GlaxoSmithKline.
 
The Program was convened by Professor Michael Brown, MOGA Deputy Chairman, and aimed to provide a comprehensive introduction to the scientific basis of cellular mechanisms and treatments used in medical oncology in order to enable advanced trainees to develop a strong knowledgebase for use in practice and clinical trials.
 
Click here to view presentations (for Trainees and Members only).
 

Sciences of Oncology Program 2011

The 2011 Sciences of Oncology Program Weekend was held on 26th-27th March 2011 at the Park Royal, Darling Harbour, Sydney, supported by an unrestricted educational grant from GlaxoSmithKline.
 
Click here to view presentations (Trainees and Members only).
 
The program covered the following topics:

• Cancer cell death - Pro-apoptotic drugs
• Chemotherapeutic resistance - HDAC Inhibitors
• DNA damage - PARP Inhibitors
• Functional imaging to assess treatment responses
• Molecular diagnostic tests - Principles and Practicalities
• Statistics in Clinical Trial

 
 
The Convener was Professor Michael Brown, Senior Staff Specialist, Department of Medical Oncology at the Royal Adelaide Hospital and Clinical Associate Professor in Medicine, University of Adelaide, is leading this initiative on behalf of MOGA.